Clinical Trial: Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Study Status: Completed
Recruit Status: RECRUITING
Condition: Spinal Cord Injuries
Study Type: INTERVENTIONAL
Official Title: Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Brief Summary:
Spinal cord injury (SCI) is associated with severe neuropathic pain that is often refractory to pharmacological intervention.Preliminary data suggest brivaracetam is a mechanism-based pharmacological intervention for neuropathic pain in SCI.Based on this and other reports in the literature, SCI-related neuropathic pain is hypothesized to occur largely because of upregulation of synaptic vesicle protein 2A (SV2A) within the substantia gelatinosa of the injured spinal cord.Furthermore, compared to placebo,…
Read more